Source Pravda.Ru

ConvaTec to belong to new owners

Private equity firms Avista Capital Partners and Nordic Capital have agreed to acquire biopharmaceutical business unit ConvaTec from Bristol-Myers Squibb Company for approximately $4.1bn, subject to adjustments based on ConvaTec's audited 2007 financial statements and closing working capital.

ConvaTec develops and markets wound therapeutics and ostomy care products. The company is headquartered in New Jersey, US and has more than 3,400 employees in 91 countries.

Nordic Capital will make the investment from its Nordic Capital VII fund.

Avista acquired Bristol-Myers Squibb Medical Imaging a few months ago for approximately $525m.

Comments
Can USA and Russia reset their relationship in Helsinki or is it a waste of time?
Militant Greek atheist Alexis Tsipras betrays his people, Orthodoxy and Russia
Putin does not exclude war with Ukraine in Donbass
The Dark side of the Moon and the western political circus
The Big Brexit mistake
The Dark side of the Moon and the western political circus
The Dark side of the Moon and the western political circus
Russian Defense Minister speaks about war with Ukraine, US and fight for Crimea
Russian Defense Minister speaks about war with Ukraine, US and fight for Crimea
Serbia will recognize Kosovo only over its dead body
Serbia will recognize Kosovo only over its dead body
Putin does not exclude war with Ukraine in Donbass
Russian government readies powerful sanctions against Ukraine
Putin does not exclude war with Ukraine in Donbass
Putin does not exclude war with Ukraine in Donbass
Putin does not exclude war with Ukraine in Donbass
Russian Defense Minister speaks about war with Ukraine, US and fight for Crimea
Russian Defense Minister speaks about war with Ukraine, US and fight for Crimea
Russian Defense Minister speaks about war with Ukraine, US and fight for Crimea
Russian Defense Minister speaks about war with Ukraine, US and fight for Crimea
Russia reveals new videos of Putin's new formidable weapons being tested